Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Hecla Mining Company Common Stock (HL) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

Hecla Mining Company Common StockTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Hecla Mining Company Common Stock vs Vir Biotechnology Inc. Common Stock — how do they compare? Hecla Mining Company Common Stock trades at $15.06 (market cap $10.87B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Hecla Mining Company Common Stock is far larger — about 6× Vir Biotechnology Inc. Common Stock's market cap, and Hecla Mining Company Common Stock pays a 0.09% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hecla Mining Company Common Stock for 3 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

HLVIR
Market Cap
$10.87B$1.80B
Volume
31,516,8481,782,836
Sector
Basic MaterialsHealth
52-Week High
$31.81$11.78
52-Week Low
$11.97$5.12
Typical Hold Time
3 Days0 Days
Enterprise Value
$10.40B$1.36B
Dividend Yield
0.09%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Hecla Mining Company Common Stock

Hecla Mining (HL) trades at $16.18, down 3.92% on the day, amid a bearish technical signal. The stock shows strong fundamentals with a 51.68% gross margin and 19.15% net income margin, but recent quarterly earnings missed expectations. Positive news highlights a debt-free balance sheet and organic growth targeting over 20 million silver ounces, while institutional activity includes new investments from Bank of America and AlphaGrep.

The outlook is mixed: analyst consensus is a Buy with a $23.44 price target, implying 45% upside, but technical indicators signal near-term pressure. Key risks include silver price volatility and execution of growth projects. The stock presents a value opportunity for long-term investors if operational targets are met.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HL
100% Buy0% Sell
Avg holding period · 3 Days
VIR
51% Buy49% Sell
Avg holding period · 0 Days

About Hecla Mining Company Common Stock

Hecla Mining is a precious metals producer focused on silver and gold. It operates mines in the United States and Canada.

Read more on HL →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →